Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 16,027 | 4,561 | 4,221 | 3,171 | 5,092 |
| Operating Income | -16,027 | -4,561 | -4,221 | -3,171 | -5,092 |
| Interest Expense | 1 | 6 | 0 | 0 | 2 |
| Other Income | 2,810 | -289 | -55 | -8,914 | -822 |
| Pre-tax Income | -13,217 | -4,856 | -4,277 | -12,085 | -5,916 |
| Net Income Continuous | -13,443 | -4,856 | -4,277 | -12,085 | -5,916 |
| Net Income | $-13,443 | $-4,856 | $-4,277 | $-12,085 | $-5,916 |
| EPS Basic Total Ops | 28.67 | -5.82 | -5.13 | -70.31 | 87.70 |
| EPS Basic Continuous Ops | 30.89 | -5.82 | -5.13 | -70.19 | 90.09 |
| EPS Diluted Total Ops | 28.67 | -5.82 | -5.13 | -70.31 | 87.70 |
| EPS Diluted Continuous Ops | 30.89 | -5.82 | -5.13 | -70.19 | 90.09 |
| EPS Diluted Before Non-Recurring Items | N/A | -5.49 | -4.94 | -16.81 | N/A |
| EBITDA(a) | $-15,982 | $-4,556 | $-4,208 | $-3,120 | $-4,970 |